Fellow of The Academy of Medical Sciences, United Kingdom
The scientist’s investigation covers issues in Prostate cancer, Prostate, Surgery, Cancer and Radiology. Mark Emberton has included themes like Biopsy and Urology in his Prostate cancer study. His Prostate research is multidisciplinary, incorporating elements of Psychological intervention, High-intensity focused ultrasound and Disease, Pathology.
His work on Radiation therapy, Urinary incontinence and Stage as part of general Surgery study is frequently linked to Context, bridging the gap between disciplines. He interconnects Adverse effect and Gynecology in the investigation of issues within Cancer. The various areas that he examines in his Radiology study include Multiparametric Magnetic Resonance Imaging, PI-RADS, Prostatectomy and Antigen levels.
Mark Emberton mostly deals with Prostate cancer, Prostate, Radiology, Internal medicine and Surgery. His Prostate cancer research entails a greater understanding of Cancer. Mark Emberton combines subjects such as Gynecology, Ablation and Medical physics with his study of Prostate.
His research in Radiology intersects with topics in Multiparametric Magnetic Resonance Imaging, Cohort, Pathology and Multiparametric MRI. His research on Internal medicine often connects related areas such as Oncology. His studies deal with areas such as Prostate biopsy and Image-Guided Biopsy as well as Biopsy.
His primary scientific interests are in Prostate cancer, Radiology, Prostate, Magnetic resonance imaging and Biopsy. Internal medicine and Cancer are the two main areas of interest in his Prostate cancer studies. He has researched Radiology in several fields, including Interquartile range, Meta-analysis, Ablation, Multiparametric MRI and Cohort.
His studies in Prostate integrate themes in fields like High-intensity focused ultrasound, Radiofrequency ablation and Medical physics. His work focuses on many connections between Magnetic resonance imaging and other disciplines, such as Ultrasound, that overlap with his field of interest in Ultrasonography. His Biopsy research includes elements of PI-RADS and Image-Guided Biopsy.
Mark Emberton spends much of his time researching Prostate cancer, Radiology, Magnetic resonance imaging, Prostate and Biopsy. Cancer and Internal medicine are inherently bound to his Prostate cancer studies. The study incorporates disciplines such as Stage, Prostate biopsy, Ablation and Cohort in addition to Radiology.
His Magnetic resonance imaging research integrates issues from Ultrasound, Meta-analysis, Disease, Distribution and First in human. His work on Prostate-specific antigen as part of general Prostate research is frequently linked to Standardization, thereby connecting diverse disciplines of science. Mark Emberton has included themes like PI-RADS, Urinary retention, Targeted biopsy and Image-Guided Biopsy in his Biopsy study.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study
Hashim U Ahmed;Hashim U Ahmed;Ahmed El-Shater Bosaily;Ahmed El-Shater Bosaily;Louise C. Brown;Rhian Gabe.
The Lancet (2017)
MRI-Targeted or Standard Biopsy for Prostate-Cancer Diagnosis
Veeru Kasivisvanathan;Antti S. Rannikko;Marcelo Borghi;Valeria Panebianco.
The New England Journal of Medicine (2018)
EAU Guidelines on the Treatment and Follow-up of Non-neurogenic Male Lower Urinary Tract Symptoms Including Benign Prostatic Obstruction
Matthias Oelke;Alexander Bachmann;Aurélien Descazeaud;Mark Emberton.
European Urology (2013)
EAU 2004 guidelines on assessment, therapy and follow-up of men with lower urinary tract symptoms suggestive of benign prostatic obstruction (BPH guidelines).
Stephan Madersbacher;Gerasimos Alivizatos;Jorgen Nordling;Carlos Rioja Sanz.
European Urology (2004)
Magnetic Resonance Imaging for the Detection, Localisation, and Characterisation of Prostate Cancer: Recommendations from a European Consensus Meeting
Louise Dickinson;Louise Dickinson;Louise Dickinson;Hashim U. Ahmed;Hashim U. Ahmed;Clare Allen;Jelle O. Barentsz.
European Urology (2011)
Systematic review of complications of prostate biopsy.
Stacy Loeb;Annelies Vellekoop;Hashim U. Ahmed;James Catto.
European Urology (2013)
Can Clinically Significant Prostate Cancer Be Detected with Multiparametric Magnetic Resonance Imaging? A Systematic Review of the Literature
Jurgen J. Fütterer;Alberto Briganti;Pieter De Visschere;Mark Emberton.
European Urology (2015)
Image-guided prostate biopsy using magnetic resonance imaging-derived targets: a systematic review.
Caroline M. Moore;Caroline M. Moore;Nicola L. Robertson;Nasr Arsanious;Thomas Middleton.
European Urology (2013)
How good is MRI at detecting and characterising cancer within the prostate
Alexander P.S. Kirkham;Mark Emberton;Clare Allen.
European Urology (2006)
Detection of Clinically Significant Prostate Cancer Using Magnetic Resonance Imaging–Ultrasound Fusion Targeted Biopsy: A Systematic Review
Massimo Valerio;Massimo Valerio;Massimo Valerio;Ian Donaldson;Mark Emberton;Mark Emberton;Behfar Ehdaie.
European Urology (2015)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:
Imperial College Healthcare NHS Trust
University College London
Institute of Cancer Research
Sunnybrook Health Science Centre
New York University
University of Southern California
University of Montreal
University of Chicago
University of South Florida
University College London
ETH Zurich
University of Adelaide
University of Sydney
Universitat Politècnica de València
General Electric (United States)
University of Southern California
ETH Zurich
University of California, Los Angeles
University of Nevada, Reno
Rockefeller University
Tufts University
Woods Hole Oceanographic Institution
University of Milan
Inserm : Institut national de la santé et de la recherche médicale
UNSW Sydney
University of Edinburgh